Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock LOGC vs. FIGS, WOOF, KRUS, CARS, ETD, GRPN, BLMN, DDL, MYTE, and SPTNShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include FIGS (FIGS), Petco Health and Wellness (WOOF), Kura Sushi USA (KRUS), Cars.com (CARS), Ethan Allen Interiors (ETD), Groupon (GRPN), Bloomin' Brands (BLMN), Dingdong (Cayman) (DDL), MYT Netherlands Parent B.V. (MYTE), and SpartanNash (SPTN). These companies are all part of the "retail/wholesale" sector. LogicBio Therapeutics vs. FIGS Petco Health and Wellness Kura Sushi USA Cars.com Ethan Allen Interiors Groupon Bloomin' Brands Dingdong (Cayman) MYT Netherlands Parent B.V. SpartanNash LogicBio Therapeutics (NASDAQ:LOGC) and FIGS (NYSE:FIGS) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Is LOGC or FIGS more profitable? FIGS has a net margin of 1.97% compared to LogicBio Therapeutics' net margin of -141.03%. FIGS's return on equity of 2.76% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LogicBio Therapeutics-141.03% -81.98% -52.13% FIGS 1.97%2.76%2.11% Does the media prefer LOGC or FIGS? In the previous week, LogicBio Therapeutics had 1 more articles in the media than FIGS. MarketBeat recorded 1 mentions for LogicBio Therapeutics and 0 mentions for FIGS. LogicBio Therapeutics' average media sentiment score of 0.00 equaled FIGS'saverage media sentiment score. Company Overall Sentiment LogicBio Therapeutics Neutral FIGS Neutral Does the MarketBeat Community favor LOGC or FIGS? LogicBio Therapeutics received 44 more outperform votes than FIGS when rated by MarketBeat users. Likewise, 64.08% of users gave LogicBio Therapeutics an outperform vote while only 47.96% of users gave FIGS an outperform vote. CompanyUnderperformOutperformLogicBio TherapeuticsOutperform Votes9164.08% Underperform Votes5135.92% FIGSOutperform Votes4747.96% Underperform Votes5152.04% Which has preferable valuation and earnings, LOGC or FIGS? FIGS has higher revenue and earnings than LogicBio Therapeutics. LogicBio Therapeutics is trading at a lower price-to-earnings ratio than FIGS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicBio Therapeutics$287M0.65-$317M-$5.79-1.23FIGS$555.56M1.43$22.64M$0.02244.25 Do insiders and institutionals hold more shares of LOGC or FIGS? 46.1% of LogicBio Therapeutics shares are owned by institutional investors. Comparatively, 92.2% of FIGS shares are owned by institutional investors. 8.1% of LogicBio Therapeutics shares are owned by company insiders. Comparatively, 22.3% of FIGS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate LOGC or FIGS? FIGS has a consensus target price of $5.35, indicating a potential upside of 9.52%. Given FIGS's stronger consensus rating and higher probable upside, analysts clearly believe FIGS is more favorable than LogicBio Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicBio Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FIGS 2 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.80 Which has more volatility & risk, LOGC or FIGS? LogicBio Therapeutics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Comparatively, FIGS has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. SummaryFIGS beats LogicBio Therapeutics on 13 of the 17 factors compared between the two stocks. Remove Ads Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$186.59M$157.53M$24.73B$8.06BDividend YieldN/AN/A171.17%4.01%P/E Ratio-1.23N/A23.8019.03Price / Sales0.650.293.9393.17Price / CashN/A3.2319.4934.64Price / Book0.791.065.654.33Net Income-$317M-$98.89M$784.47M$247.06M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics0.6653 of 5 stars$7.10-1.3%N/AN/A$186.59M$287M-1.2362FIGSFIGS1.145 of 5 stars$4.84+11.7%$5.35+10.7%-1.9%$785.78M$555.56M80.58310WOOFPetco Health and Wellness2.9575 of 5 stars$2.47+1.2%$4.28+73.2%+46.6%$774.22M$6.24B-6.1829,000Analyst ForecastOptions VolumeNews CoverageGap UpKRUSKura Sushi USA3.5967 of 5 stars$61.77+12.0%$86.20+39.5%-54.7%$745.32M$250.84M-90.842,100Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsGap UpCARSCars.com3.5983 of 5 stars$12.32+5.8%$20.50+66.4%-31.3%$743.18M$719.15M21.241,700Analyst ForecastNews CoverageETDEthan Allen Interiors3.2343 of 5 stars$28.50+3.4%$32.00+12.3%-17.8%$724.81M$626.65M11.983,404Positive NewsGRPNGroupon2.6329 of 5 stars$17.99+5.3%$17.75-1.3%+46.9%$716.20M$492.56M35.283,680Options VolumeBLMNBloomin' Brands4.3889 of 5 stars$8.43+8.4%$14.50+72.0%-71.9%$715.97M$3.95B-76.6387,000Short Interest ↓DDLDingdong (Cayman)2.8778 of 5 stars$2.92+0.5%N/A+139.2%$688.61M$23.07B32.394,000Positive NewsMYTEMYT Netherlands Parent B.V.1.8481 of 5 stars$7.91+0.8%$14.00+77.0%+147.4%$674.37M$881.44M-18.391,240Short Interest ↑SPTNSpartanNash3.4902 of 5 stars$19.55-0.4%$15.00-23.3%+0.1%$660.11M$9.55B-1,955.0016,500Analyst Downgrade Remove Ads Related Companies and Tools Related Companies FIGS Alternatives Petco Health and Wellness Alternatives Kura Sushi USA Alternatives Cars.com Alternatives Ethan Allen Interiors Alternatives Groupon Alternatives Bloomin' Brands Alternatives Dingdong (Cayman) Alternatives MYT Netherlands Parent B.V. Alternatives SpartanNash Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOGC) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LOGC Stock Free LOGC Stock Alerts